Neoplasene: the Future

Research is ongoing with Neoplasene, and the protocols and treatment methods are constantly changing. The effects of bloodroot’s active ingredients have not been researched aggressively, because most pharmaceutical companies will not spend money on something that they may not be able to patent, such as a plant. However, there is an astounding study on the effects of bloodroot on cancer from the medical school at Case Western Reserve University in Cleveland, Ohio, done in 2000. This study was done in vitro with prostate cancer cells and skin cancer cells. The results were so clearly impressive the researchers remarked, “We suggest that sanguinarine could be developed as an anticancer drug.” The clinical case histories from veterinary hospitals throughout the U.S. are now accumulating, and are adding to the profound data of this very promising drug.